Tradjenta (Linagliptin) for Diabetes | DiabetesTeam

Connect with others who understand.

sign up Log in
Resources
About DiabetesTeam
Powered By

Overview
Tradjenta is a prescription drug approved by the Food and Drug Administration (FDA) to help improve blood glucose control in adults with type 2 diabetes. Tradjenta is considered an adjunct treatment to diet and exercise. Tradjenta is also referred to by its drug name, Linagliptin.

Tradjenta is a dipeptidyl peptidase 4 (DPP-4) inhibitor. Tradjenta is believed to work by lowering blood glucose levels when they are elevated.

How do I take it?
Prescribing information states that Tradjenta is generally taken once daily with or without food.

Tradjenta comes in tablet form.

Side effects
The FDA-approved label for Tradjenta lists common side effects including flu-like symptoms, upper respiratory infection, and headache.

Rare but serious side effects listed for Tradjenta include pancreatitis, liver problems, and systemic allergic reaction.

Continue with Facebook
Continue with Google
Your privacy is our priority. By continuing, you accept our Terms of use and Privacy policy.
Already a Member? Log in